Are Concerns Over Avacopan Efficacy Overblown?
(MedPage Today) -- Avacopan (Tavneos), the complement pathway inhibitor for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), appeared strongly effective in an Italian registry study -- a step, maybe, toward setting to rest...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.